A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea

Resistance of <i>Cutibacterium acnes</i> to topical antibiotics historically used to treat acne (topical erythromycin and clindamycin and, more recently, topical azithromycin and clarithromycin) has been steadily increasing and new topical antibiotics are needed. Minocycline is a semisyn...

Full description

Bibliographic Details
Main Authors: Ana M. Martins, Joana M. Marto, Jodi L. Johnson, Emmy M. Graber
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/7/757
_version_ 1827689104117071872
author Ana M. Martins
Joana M. Marto
Jodi L. Johnson
Emmy M. Graber
author_facet Ana M. Martins
Joana M. Marto
Jodi L. Johnson
Emmy M. Graber
author_sort Ana M. Martins
collection DOAJ
description Resistance of <i>Cutibacterium acnes</i> to topical antibiotics historically used to treat acne (topical erythromycin and clindamycin and, more recently, topical azithromycin and clarithromycin) has been steadily increasing and new topical antibiotics are needed. Minocycline is a semisynthetic tetracycline-derived antibiotic currently used systemically to treat a wide range of infections caused by Gram-negative and Gram-positive bacteria. In addition to its antibiotic activity, minocycline possesses anti-inflammatory properties, such as the downregulation of proinflammatory cytokine production, suppression of neutrophil chemotaxis, activation of superoxide dismutase, and inhibition of phagocytosis, among others. These characteristics make minocycline a valuable agent for treatment of dermatological diseases such as acne vulgaris and papulopustular rosacea. However, more frequent or serious adverse effects have been observed upon the systemic administration of minocycline than with other tetracyclines. Examples of serious adverse effects include hypersensitivity syndrome reaction, drug-induced lupus, idiopathic intracranial hypertension, and other autoimmune syndromes that may cause death. Here, we review adverse effects and drug–drug interactions observed with oral administration of minocycline and contrast this with topical minocycline formulations recently approved or under development for effectively treating dermatological disorders with fewer adverse effects and less drug interaction.
first_indexed 2024-03-10T10:11:07Z
format Article
id doaj.art-da32ab3f5f504b2fb6262822bd816dde
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T10:11:07Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-da32ab3f5f504b2fb6262822bd816dde2023-11-22T01:13:06ZengMDPI AGAntibiotics2079-63822021-06-0110775710.3390/antibiotics10070757A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and RosaceaAna M. Martins0Joana M. Marto1Jodi L. Johnson2Emmy M. Graber3Research Institute for Medicine (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalResearch Institute for Medicine (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, PortugalDepartments of Pathology and Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USAThe Dermatology Institute, Boston, MA 02116, USAResistance of <i>Cutibacterium acnes</i> to topical antibiotics historically used to treat acne (topical erythromycin and clindamycin and, more recently, topical azithromycin and clarithromycin) has been steadily increasing and new topical antibiotics are needed. Minocycline is a semisynthetic tetracycline-derived antibiotic currently used systemically to treat a wide range of infections caused by Gram-negative and Gram-positive bacteria. In addition to its antibiotic activity, minocycline possesses anti-inflammatory properties, such as the downregulation of proinflammatory cytokine production, suppression of neutrophil chemotaxis, activation of superoxide dismutase, and inhibition of phagocytosis, among others. These characteristics make minocycline a valuable agent for treatment of dermatological diseases such as acne vulgaris and papulopustular rosacea. However, more frequent or serious adverse effects have been observed upon the systemic administration of minocycline than with other tetracyclines. Examples of serious adverse effects include hypersensitivity syndrome reaction, drug-induced lupus, idiopathic intracranial hypertension, and other autoimmune syndromes that may cause death. Here, we review adverse effects and drug–drug interactions observed with oral administration of minocycline and contrast this with topical minocycline formulations recently approved or under development for effectively treating dermatological disorders with fewer adverse effects and less drug interaction.https://www.mdpi.com/2079-6382/10/7/757minocyclinetetracyclineacne vulgarisrosacea
spellingShingle Ana M. Martins
Joana M. Marto
Jodi L. Johnson
Emmy M. Graber
A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
Antibiotics
minocycline
tetracycline
acne vulgaris
rosacea
title A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
title_full A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
title_fullStr A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
title_full_unstemmed A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
title_short A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea
title_sort review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea
topic minocycline
tetracycline
acne vulgaris
rosacea
url https://www.mdpi.com/2079-6382/10/7/757
work_keys_str_mv AT anammartins areviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT joanammarto areviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT jodiljohnson areviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT emmymgraber areviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT anammartins reviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT joanammarto reviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT jodiljohnson reviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea
AT emmymgraber reviewofsystemicminocyclinesideeffectsandtopicalminocyclineasasaferalternativefortreatingacneandrosacea